Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-18T15:24:02.306Z Has data issue: false hasContentIssue false
  • English
  • Français

First Successful Pre-Distribution of Stable Iodine Tablets Under Japan’s New Policy After the Fukushima Daiichi Nuclear Accident

Published online by Cambridge University Press:  08 December 2016

Mayo Ojino ,
Sumito Yoshida ,
Takashi Nagata ,
Masami Ishii  and
Makoto Akashi
Mayo Ojino*
Affiliation:
Japan Medical Association Research Institute, Tokyo, Japan
Sumito Yoshida
Affiliation:
Japan Medical Association Research Institute, Tokyo, Japan
Takashi Nagata
Affiliation:
Kyushu University, Faculty of Medical Sciences, Department of Advanced Medical Initiative, Fukuoka-city, Japan
Masami Ishii
Affiliation:
Japan Medical Association, Tokyo, Japan Medical & Social Welfare Corporation/Seife-kai group, Iwaki City, Japan
Makoto Akashi
Affiliation:
National Institutes for Quantum and Radiological Science and Technology, Chiba City, Japan.
*
Correspondence and reprint requests to Mayo Ojino, Japan Medical Association Research Institute, 2-28-16 Honkomagome, Bunkyo-ku Tokyo, 113-8621 (E-mail: [email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

Stable iodine tablets are effective in reducing internal exposure to radioactive iodine, which poses a risk for thyroid cancer and other conditions. After the Fukushima Daiichi nuclear power plant accident, the Japanese government shifted its policy on stable iodine tablet distribution from “after-the-fact” to “before-the-fact” and instructed local governments to pre-distribute stable iodine tablets to residents living within a 5-km radius of nuclear facilities. The nation’s first pre-distribution of stable iodine tablets was carried out in June and July of 2014 in Kagoshima Prefecture. Health surveys were conducted so that the medication would not be handed out to people with the possibility of side effects. Of the 4715 inhabitants in the area, 132 were found to require a physician’s judgment, mostly to exclude risks of side effects. This was considered important to prevent the misuse of the tablets in the event of a disaster. The importance of collective and individualized risk communication between physicians and inhabitants at the community health level was apparent through this study. Involvement of physicians through the regional Sendai City Medical Association was an important component of the pre-distribution. Physicians of the Sendai City Medical Association were successfully educated by using the Guidebook on Distributing and Administering Stable Iodine Tablets prepared by the Japan Medical Association and Japan Medical Association Research Institute with the collaboration of the National Institute of Radiological Sciences and the Japanese government. Thus, the physicians managed to make decisions on the dispensing of stable iodine tablets according to the health conditions of the inhabitants. All physicians nationwide should be provided continuing medical education on stable iodine tablets. (Disaster Med Public Health Preparedness. 2017;11:365–369)

Keywords

stable iodine administrationpre-distributionFukushima Daiichi nuclear power plant accidentphysician traininghealth survey
Type
Concepts in Disaster Medicine
Information
Disaster Medicine and Public Health Preparedness , Volume 11 , Issue 3 , June 2017 , pp. 365 - 369
Copyright
Copyright © Society for Disaster Medicine and Public Health, Inc. 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Yoshida, S, Ojino, M, Ozaki, T, et al. Guidelines for iodine prophylaxis as a protective measure: information for physicians. Japan Med Assoc J. 2014;57(3):113-123.Google ScholarPubMed
2. Investigation Committee on the Accident at Fukushima Nuclear Power Stations of Tokyo Electric Power Company. The Final Report of Investigation Committee on the Accident at Fukushima Nuclear Power Stations of Tokyo Electric Power Company. Website. http://www.cas.go.jp/jp/seisaku/icanps/eng/05IVfinal.pdf. Published 2012. Accessed September 2, 2016.Google Scholar
3. Shimura, T, Yamaguchi, I, Terada, H, et al. Public health activities for mitigation of radiation exposures and risk communication challenges after the Fukushima nuclear accident. J Radiat Res (Tokyo). 2015;56(3):422-429. http://dx.doi.org/10.1093/jrr/rrv013.Google Scholar
4. Ojino, M. Radiation emergency medicine: future systems and responses based on the lessons learned from the Fukushima Daiichi nuclear power plant accident [in Japanese]. Japan Medical Association Research Institute Working Paper. 2013;275.Google Scholar
5. Nuclear Regulation Authority. Minutes of the third meeting of the study team on emergency radiation medicine [in Japanese]. Tokyo, Japan: Nuclear Regulation Authority; 2014.Google Scholar
6. Miki, T, Ebata, H, Hisadome, T, et al. What Are the Roles of Home Doctors in Radiation Emergency? Presented at: The Japanese Radiation Research Society 57th Annual Meeting; 2014; Kagoshima city, Japan.Google Scholar
7. Japan Medical Association. Guidebook on Distributing and Administering Stable Iodine Tablets in the Event of a Nuclear Disaster [in Japanese]. Tokyo, Japan: Japan Medical Association; 2014.Google Scholar
8. French Nuclear Safety Authority. Annual Report 2006: Nuclear Safety and Radiation Protection in France in 2006. ASN website. http://www.asn.fr/annual_report/2006/report-2006.html. Published March 6, 2007. Accessed November 21, 2015.Google Scholar
9. US Nuclear Regulatory Commission. Consideration of potassium iodide in emergency planning. US NRC website. http://www.nrc.gov/about-nrc/emerg-preparedness/about-emerg-preparedness/potassium-iodide.html. Accessed November 21, 2015.Google Scholar
10. Fowinkle, EW, Sell, SH, Wolle, RH. Predistribution of potassium iodide – the Tennessee experience. Public Health Rep. 1983;98(2):123-126.Google Scholar
11. French Nuclear Safety Authority. Distribution d’iode website. http://www.distribution-iode.com/. Accessed November 21, 2015.Google Scholar
12. Ojino, M, Yoshida, S. Pre-distribution of stable iodine tablets in preparation for a nuclear disaster and associated problems: a case report on the pre-distribution of stable iodine tablets in Kagoshima Prefecture [in Japanese]. Japan Medical Association Research Institute Working Paper. 2014;325.Google Scholar
13. The National Diet of Japan Fukushima Nuclear Accident Independent Investigation Commission. The Official Report of the Fukushima Nuclear Accident Independent Investigation Commission. Tokyo, Japan: NAIIC; 2012.Google Scholar
14. Nagata, T, Kimura, Y, Ishii, M. Use of a geographic information system (GIS) in the medical response to the Fukushima nuclear disaster in Japan. Prehosp Disaster Med. 2012;27(2):213-215. http://dx.doi.org/10.1017/S1049023X1200060X.Google Scholar
15. Ishii, M, Nagata, T. The Japan Medical Association’s disaster preparedness: lessons from the Great Eastern Japan Earthquake and Tsunami. Disaster Med Public Health Prep. 2013;7(5):507-512. http://dx.doi.org/10.1017/dmp.2013.97.Google Scholar